RMD Resmed Inc stock chart & analysis
Conviction 59HealthcareScan · Fri, Nov 6, 2026Resmed Inc (RMD) closed at $235.30 (-1.68%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 48, RS Rating 67, -15.3% from its 52-week high, -2.4% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.
Financials as of Wed, Sep 30, 2026 · quarterly.
RMD technical analysis
Trend
RMD is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 1.5% above the 50-day ($231.86) and 4.9% above the 200-day ($224.33). ADX(14) at 28 points to a strong, established trend. It meets 4 of 8 trend-template criteria.
Momentum
RSI(14) is 48, in the bearish half of its range. MACD crossed below its signal line 5 sessions ago. Its RS Rating of 67 puts its weighted 12-month performance ahead of about 67% of the US market.
Volume and volatility
Volume on the latest session ran 0.8× its 20-day average. It trades about $351.4M a day on average. ATR(14) is $8.09, 3.4% of price — its typical daily range. Chaikin Money Flow (0.19) shows accumulation.
Key levels
The chart pattern's support is $218.76 and its resistance $254.92. The 52-week range is $180.27 to $277.67; price is 15.3% below the high and 30.5% above the low. The VWAP anchored at the 52-week high is $220.01, below price.
Performance
RMD returned +2.3% (1 week), +3.7% (1 month), +6.9% (3 months), +13.8% (6 months), -4.1% (1 year), -2.4% (year to date).
About Resmed Inc
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
Surgical & Medical Instruments & Apparatus · Listed 1995 · 10,600 employees
Congress activity
Disclosed STOCK Act trades in RMD · 6 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 Kelly Louise Morrison house · D · MN · traded 2025-06-04 | Sell | $1K–$15K | 2025-06-04 | 2025-06-18 | |
Kelly Louise Morrison house · D · MN · traded 2025-04-28 | Sell | $1K–$15K | 2025-04-28 | 2025-05-13 | |
 Rob Bresnahan house · PA · traded 2025-01-13 | Sell | $1K–$15K | 2025-01-13 | 2025-02-13 | |
Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2024-06-14 |
Insider activity
SEC Form 4 transactions in RMD · open-market 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Rider Michael J Global General Counsel · ResMed Common Stock · 2026-10-23 | Sell | 400 | $102K | 2026-10-23 | 2026-10-26 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-08-07 | Exercise | 4.99K | $730K | 2026-08-07 | 2026-08-11 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-08-07 | Sell | 4.99K | $1.0M | 2026-08-07 | 2026-08-11 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock Options · 2026-08-07 | Exercise | 4.99K | — | 2026-08-07 | 2026-08-11 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-07-07 | Exercise | 4.99K | $730K | 2026-07-07 | 2026-07-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-07-07 | Sell | 4.99K | $1.1M | 2026-07-07 | 2026-07-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock Options · 2026-07-07 | Exercise | 4.99K | — | 2026-07-07 | 2026-07-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-06-08 | Exercise | 4.99K | $730K | 2026-06-08 | 2026-06-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-06-08 | Sell | 4.99K | $968K | 2026-06-08 | 2026-06-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock Options · 2026-06-08 | Exercise | 4.99K | $0 | 2026-06-08 | 2026-06-09 |
SEC filings
EDGAR filings in RMD · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.